Stocktoria
Vaxcyte, Inc. PCVX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-06-12
Vaxcyte, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 9,939,846 | $750.6M |
| D. E. Shaw & Co., Inc. | 2,865,318 | $166.5M |
| Point72 Asset Management, L.P. | 620,401 | $36.1M |
| MILLENNIUM MANAGEMENT LLC | 293,695 | $17.1M |
| CITADEL ADVISORS LLC | 197,600 | $11.5M |
| TWO SIGMA INVESTMENTS, LP | 111,310 | $6.5M |
| RENAISSANCE TECHNOLOGIES LLC | 54,734 | $3.2M |
| AQR CAPITAL MANAGEMENT LLC | 25,458 | $1.5M |
Source: SEC EDGAR filings · CIK 0001649094 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.